Gases in Sepsis: Novel Mediators and Therapeutic Targets
Sepsis, a potentially lethal condition resulting from failure to control the initial infection, is associated with a dysregulated host defense response to pathogens and their toxins. Sepsis remains a leading cause of morbidity, mortality and disability worldwide. The pathophysiology of sepsis is ver...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/7/3669 |
_version_ | 1797439081972498432 |
---|---|
author | Zhixing Zhu Stephen Chambers Yiming Zeng Madhav Bhatia |
author_facet | Zhixing Zhu Stephen Chambers Yiming Zeng Madhav Bhatia |
author_sort | Zhixing Zhu |
collection | DOAJ |
description | Sepsis, a potentially lethal condition resulting from failure to control the initial infection, is associated with a dysregulated host defense response to pathogens and their toxins. Sepsis remains a leading cause of morbidity, mortality and disability worldwide. The pathophysiology of sepsis is very complicated and is not yet fully understood. Worse still, the development of effective therapeutic agents is still an unmet need and a great challenge. Gases, including nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H<sub>2</sub>S), are small-molecule biological mediators that are endogenously produced, mainly by enzyme-catalyzed reactions. Accumulating evidence suggests that these gaseous mediators are widely involved in the pathophysiology of sepsis. Many sepsis-associated alterations, such as the elimination of invasive pathogens, the resolution of disorganized inflammation and the preservation of the function of multiple organs and systems, are shaped by them. Increasing attention has been paid to developing therapeutic approaches targeting these molecules for sepsis/septic shock, taking advantage of the multiple actions played by NO, CO and H<sub>2</sub>S. Several preliminary studies have identified promising therapeutic strategies for gaseous-mediator-based treatments for sepsis. In this review article, we summarize the state-of-the-art knowledge on the pathophysiology of sepsis; the metabolism and physiological function of NO, CO and H<sub>2</sub>S; the crosstalk among these gaseous mediators; and their crucial effects on the development and progression of sepsis. In addition, we also briefly discuss the prospect of developing therapeutic interventions targeting these gaseous mediators for sepsis. |
first_indexed | 2024-03-09T11:46:34Z |
format | Article |
id | doaj.art-7b58953e3d394734baceb936a5a4be02 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-09T11:46:34Z |
publishDate | 2022-03-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-7b58953e3d394734baceb936a5a4be022023-11-30T23:20:20ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-03-01237366910.3390/ijms23073669Gases in Sepsis: Novel Mediators and Therapeutic TargetsZhixing Zhu0Stephen Chambers1Yiming Zeng2Madhav Bhatia3Department of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New ZealandDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New ZealandDepartment of Internal Medicine (Pulmonary and Critical Care Medicine), The Second Clinical Medical School of Fujian Medical University, Quanzhou 362002, ChinaDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New ZealandSepsis, a potentially lethal condition resulting from failure to control the initial infection, is associated with a dysregulated host defense response to pathogens and their toxins. Sepsis remains a leading cause of morbidity, mortality and disability worldwide. The pathophysiology of sepsis is very complicated and is not yet fully understood. Worse still, the development of effective therapeutic agents is still an unmet need and a great challenge. Gases, including nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H<sub>2</sub>S), are small-molecule biological mediators that are endogenously produced, mainly by enzyme-catalyzed reactions. Accumulating evidence suggests that these gaseous mediators are widely involved in the pathophysiology of sepsis. Many sepsis-associated alterations, such as the elimination of invasive pathogens, the resolution of disorganized inflammation and the preservation of the function of multiple organs and systems, are shaped by them. Increasing attention has been paid to developing therapeutic approaches targeting these molecules for sepsis/septic shock, taking advantage of the multiple actions played by NO, CO and H<sub>2</sub>S. Several preliminary studies have identified promising therapeutic strategies for gaseous-mediator-based treatments for sepsis. In this review article, we summarize the state-of-the-art knowledge on the pathophysiology of sepsis; the metabolism and physiological function of NO, CO and H<sub>2</sub>S; the crosstalk among these gaseous mediators; and their crucial effects on the development and progression of sepsis. In addition, we also briefly discuss the prospect of developing therapeutic interventions targeting these gaseous mediators for sepsis.https://www.mdpi.com/1422-0067/23/7/3669sepsispathophysiologygaseous mediatorsNOCOH<sub>2</sub>S |
spellingShingle | Zhixing Zhu Stephen Chambers Yiming Zeng Madhav Bhatia Gases in Sepsis: Novel Mediators and Therapeutic Targets International Journal of Molecular Sciences sepsis pathophysiology gaseous mediators NO CO H<sub>2</sub>S |
title | Gases in Sepsis: Novel Mediators and Therapeutic Targets |
title_full | Gases in Sepsis: Novel Mediators and Therapeutic Targets |
title_fullStr | Gases in Sepsis: Novel Mediators and Therapeutic Targets |
title_full_unstemmed | Gases in Sepsis: Novel Mediators and Therapeutic Targets |
title_short | Gases in Sepsis: Novel Mediators and Therapeutic Targets |
title_sort | gases in sepsis novel mediators and therapeutic targets |
topic | sepsis pathophysiology gaseous mediators NO CO H<sub>2</sub>S |
url | https://www.mdpi.com/1422-0067/23/7/3669 |
work_keys_str_mv | AT zhixingzhu gasesinsepsisnovelmediatorsandtherapeutictargets AT stephenchambers gasesinsepsisnovelmediatorsandtherapeutictargets AT yimingzeng gasesinsepsisnovelmediatorsandtherapeutictargets AT madhavbhatia gasesinsepsisnovelmediatorsandtherapeutictargets |